Travere Therapeutics, Inc. TVTX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s interest expense?
- Travere Therapeutics, Inc. (TVTX) reported interest expense of $2.3M in Q1 2026.
- How has Travere Therapeutics, Inc.'s interest expense changed year-over-year?
- Travere Therapeutics, Inc.'s interest expense decreased by 19.5% year-over-year, from $2.86M to $2.3M.
- What is the long-term trend for Travere Therapeutics, Inc.'s interest expense?
- Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s interest expense has grown at a -14.0% compound annual growth rate (CAGR), from -$19.68M to $10.75M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.